Original language | English |
---|---|
Pages (from-to) | e379-e380 |
Journal | The Lancet Rheumatology |
Volume | 4 |
Issue number | 6 |
DOIs |
|
State | Published - Jun 2022 |
Immunosuppression and SARS-CoV-2 breakthrough infections
Alfred H.J. Kim, Jeffrey A. Sparks
- Division of Rheumatology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute for Public Health
- Institute of Clinical and Translational Sciences (ICTS)
- Rheumatic Diseases Research Resource-Based Center
- COVID-19 Researchers
- DBBS - Immunology
Research output: Contribution to journal › Comment/debate
10
Scopus
citations